IRIS Accounts Production v24.2.0.383 12277281 Board of Directors 1.11.22 31.10.23 31.10.23 false true false false false 70 38945 1196052 38875 1196122 70 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122772812022-10-31122772812023-10-31122772812022-11-012023-10-31122772812021-10-31122772812021-11-012022-10-31122772812022-10-3112277281ns15:EnglandWales2022-11-012023-10-3112277281ns14:PoundSterling2022-11-012023-10-3112277281ns10:Director12022-11-012023-10-3112277281ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3112277281ns10:Micro-entities2022-11-012023-10-3112277281ns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3112277281ns10:FullAccounts2022-11-012023-10-311227728141ns10:Director12022-10-311227728141ns10:Director12021-10-311227728141ns10:Director12022-11-012023-10-311227728141ns10:Director12021-11-012022-10-311227728141ns10:Director12023-10-311227728141ns10:Director12022-10-3112277281ns5:CurrentFinancialInstruments2023-10-3112277281ns5:CurrentFinancialInstruments2022-10-3112277281ns5:Non-currentFinancialInstruments2023-10-3112277281ns5:Non-currentFinancialInstruments2022-10-3112277281ns10:RegisteredOffice2022-11-012023-10-3112277281ns10:Director22022-11-012023-10-3112277281ns10:Director222022-10-3112277281ns10:Director222021-10-3112277281ns10:Director222022-11-012023-10-3112277281ns10:Director222021-11-012022-10-3112277281ns10:Director222023-10-3112277281ns10:Director222022-10-31
REGISTERED NUMBER: 12277281 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

D&A Pharma Services Ltd

D&A Pharma Services Ltd (Registered number: 12277281)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Balance Sheet 1


D&A Pharma Services Ltd (Registered number: 12277281)

Balance Sheet
31 October 2023

31.10.23 31.10.22
£    £    £    £   
FIXED ASSETS 84,360 108,654

CURRENT ASSETS 1,744,648 79,216

PREPAYMENTS AND ACCRUED INCOME 78,803 21,673

CREDITORS
Amounts falling due within one year (1,776,491 ) (106,188 )
NET CURRENT ASSETS/(LIABILITIES) 46,960 (5,299 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

131,320

103,355

CREDITORS
Amounts falling due after more than one
year

(55,819

)

(71,848

)

ACCRUALS AND DEFERRED INCOME - (3,000 )
NET ASSETS 75,501 28,507

CAPITAL AND RESERVES 75,501 28,507

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

D&A Pharma Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12277281

Registered office: High Firs
Ling Lane
Leeds
West Yorkshire
LS14 3HX

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2022 - 3 ) .

D&A Pharma Services Ltd (Registered number: 12277281)

Balance Sheet - continued
31 October 2023

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2023 and 31 October 2022:

31.10.23 31.10.22
£    £   
Mrs A D Lee and Mr D M Lee
Balance outstanding at start of year (70 ) (38,945 )
Amounts repaid (1,196,052 ) 38,875
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,196,122 ) (70 )



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2024 and were signed on its behalf by:





Mr D M Lee - Director